MARKET

ADTX

ADTX

ADiTx Therapeutics, Inc.
NASDAQ

Real-time Quotes | Nasdaq Last Sale

1.935
-0.065
-3.25%
Opening 12:39 10/30 EDT
OPEN
1.990
PREV CLOSE
2.000
HIGH
1.990
LOW
1.880
VOLUME
258.79K
TURNOVER
--
52 WEEK HIGH
9.58
52 WEEK LOW
1.620
MARKET CAP
10.22M
P/E (TTM)
-3.2148
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
SNAP, NKLA, PINS and ERIC among premarket gainers
Astrotech Corporation (ASTC) +145% in reaction to its partnership with Cleveland Clinic.Marin Software (MRIN) +138%.NetSol Technologies (NTWK) +67% after its platform goes live in China.VOC Energy Trust (VOC) +27%.Greenpro Capital (GRNQ) +13%.Snap (SNAP) +22% on Q3
Seekingalpha · 10/21 12:21
Aditxt Announces First AditxtEngage Event, Continuing Series of Investor Opportunities to Engage with Company
First AditxtEngage™Event with Amro Albanna, CEO, to be held on Tuesday, October 6that 4:30pm ET Mountain View, CA, Oct. 02, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire \-- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically
GlobeNewswire · 10/02 21:05
Former Chief Medical Officer and Assistant Secretary for Health Affairs of the U.S. Department of Homeland Security, Dr. Jeffrey Runge, Appointed to Aditxt Board of Directors
Mountain View, CA, Oct. 01, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming
GlobeNewswire · 10/01 13:00
BIG, FIT among premarket gainers
U.S. Energy (USEG) +168% after entering producing assets purchase agreement.Houston American Energy (HUSA) +77%.PEDEVCO (PED) +56%.Greenpro Capital Corp. (GRNQ) +53%.Flux Power Holdings (FLUX) +36% on FY results.Mexco Energy (MXC) +33%.Westwater Resources (WWR) +30%.New Concept
Seekingalpha · 09/29 12:23
The Daily Biotech Pulse: Novavax Advances Vaccine, Marinus Gets Nod For Late-Stage Study, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 24)
Benzinga · 09/25 11:37
Owens & Minor, Kaleido Biosciences among major healthcare gainers, MediciNova, Rite Aid leads losers pack
Gainers: Owens & Minor (OMI) +53%, Kaleido Biosciences (KLDO) +39%, LogicBio Therapeutics (LOGC) +30%,  Cellect Biotechnology (APOP) +25%, Neuronetics (STIM) +6%.Losers: MediciNova (MNOV) -20%, Rite Aid (RAD) -17%, ADiTx Therapeutics (ADTX) -12%, NanoVibronix (NAOV) -12%, Rockwell Medical (RMTI) -10%.
Seekingalpha · 09/24 15:00
Aditx Therapeutics to Present at H.C. Wainwright 22nd Annual Global Investment Conference
Virtual Presentation on Wednesday, September 16th at 3:00 PM EDT Loma Linda, CA, Sept. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the "Company") (NASDAQ:ADTX), a life sciences company developing biotechnologies focused on improving the health of the
GlobeNewswire · 09/10 21:30
Physician and Media Personality Dr. Drew Pinsky, Dr. Drew, Joins Aditx Therapeutics as Senior Advisor to AditxtScore for Scoring the Immune System
Dr Drew Dr. Drew PinskyWill Serve as Advisor and Brand Ambassador to Overall Platform and Individual Applications Loma Linda, CA, Sept. 10, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies
GlobeNewswire · 09/10 13:51
More
Forecast
EPSBVPSCFPS
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of ADTX. Analyze the recent business situations of ADiTx Therapeutics, Inc. through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Institutional Holdings
Institutions: 4
Institutional Holdings: 209.29K
% Owned: 3.96%
Shares Outstanding: 5.28M
TypeInstitutionsShares
Increased
0
0
New
3
98.83K
Decreased
0
0
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-2.37%
Pharmaceuticals & Medical Research
-1.32%
Key Executives
Chairman/President/Chief Executive Officer/Director
Amro Albanna
Chief Financial Officer
Corinne Pankovcin
Chief Operating Officer
Rowena Albanna
Other/Director
Shahrokh Shabahang
Independent Director
Laura Anthony
Independent Director
Brian Brady
Independent Director
Namvar Kiaie
Independent Director
Jeffrey Runge
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About ADTX
Aditx Therapeutics, Inc. is a pre-clinical stage, life sciences company. The Company is focused on developing technologies on improving the health of the immune system through immune reprogramming and monitoring. The Company’s immune reprogramming technology is at the pre-clinical stage and is designed to retrain the immune system to induce tolerance. The Company’s immune monitoring technology is designed to provide a personalized profile of the immune system. The Company is developing nucleic acid-based technology, Apoptotic DNA Immunotherapy (ADi) that mimics the way human body naturally induces tolerance to its tissues. The Company is developing Aditxt Immune Monitor (AiM), which provides a personalized comprehensive profile of the immune system.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of ADiTx Therapeutics Inc stock information, including NASDAQ:ADTX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ADTX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading ADTX stock methods without spending real money on the virtual paper trading platform.